Werkgroep Cardiologische centra Nederland English

AVANT GARDE (Klaar)

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation and Dose-Confirmation Study to Evaluate the Safety and Efficacy of Rivaroxaban in Combination with Aspirin Alone or with Aspirin and a Thienopyridine in Subjects with Acute Coronary SyndromesA randomized, double-blind, parallel-group, placebocontrolled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in stabilized patients post acute coronary syndromes

Middel
aliskiren
Populatie
acuut coronair syndroom
Fase
II
Jaar aanvang
2006